TABLE-Taisho Pharm <4535.T>-6mth group results

Related Topics

Thu Oct 29, 2009 11:30pm EDT 

   Oct 30 (Reuters) -
                TAISHO PHARMACEUTICAL CO LTD
                CONSOLIDATED FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
            6 months ended  6 months ended  Full year to    Full year ended
               Sep 30, 2009    Sep 30, 2008    Mar 31, 2010    Mar 31, 2009
               LATEST          YEAR-AGO        COMPANY         YEAR-AGO  
               H1 RESULTS      H1 RESULTS      FORECAST        RESULTS   
 Sales             129.76          126.31          262.00                   
                 (+2.7 pct)                         (+2.3%)              
 Operating          18.20           19.48           34.50                   
                 (-6.6 pct)                         (-9.1%)              
 Recurring          18.86           20.76           36.00                   
                 (-9.2 pct)                         (-9.8%)              
 Net           prft 10.36       loss 1.05      prft 19.50                   
                                                  (+121.2%)              
 EPS              prft Y36.14      loss Y3.56     prft Y67.99               
 Annual div                                            Y27.00          Y27.00
  -Q2 div              Y12.00          Y12.00                               
  -Q4 div                              Y15.00          Y15.00               
 NOTE - Taisho Pharmaceutical Co Ltd is a top-ranked maker of non-prescription drugs.
 For latest earnings estimates made by Toyo Keizai, please
double click on 4535.TK1.
Healthcare
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.